Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Position of strength…. I hope this fits the definition

<< Previous

Bullboard Posts

Next >>

Comment by Lee430on Apr 10, 2024 8:20pm

55 Views

Post# 35982428

RE:RE:RE:Position of strength…. I hope this fits the definition

I believe last year’s AGM was our final opportunity to force a BOD change, they made sure we paid dearly for challenging them last year and my opinion is still that they have ZERO ethics.

Trogarzon wrote: Lets not be fooled onece again by the all the talks about future value creation. The future is May 9th 2024... after that more excuses for sales not rebounding and need for more dilution of you and me. It's the absolute last time we can do anything about it.

<< Previous

Bullboard Posts

Next >>

Bombardier Defense expands in Australia